Insilico Medicine

China–UAE News

Insilico Medicine Leaders to Share AI Drug Discovery Insights in Shanghai and Dubai

Insilico Medicine announced that its senior leadership will present at major healthcare and AI summits across China and Dubai in November 2026. Global Business Development Head Dr. Jue Wang will speak in Shanghai, while Co-Founder and President Dr. Alex Aliper will join an investor panel in Dubai. The company also reported nominating 11 preclinical drug candidates in the first ten months of 2026.

Industry News

UAE Investments in AI and Genomics Drive Middle East Biopharma Expansion

A report by World Health Expo and Frost & Sullivan indicates that UAE national investments in genomics, artificial intelligence, and advanced manufacturing are transforming Middle Eastern biopharma. The regional precision medicine sector is forecast to expand by over 10 percent over the next five to seven years. Key initiatives include the Emirati Genome Program, Abu Dhabi's AED 42 billion HELM cluster, and the 2025 launch of Mubadala Bio.